Works by Rowinsky, Eric K.

Results: 30

Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 167, doi. 10.1007/s00280-009-1020-y

By:

Chia-Chi Lin;
Beeram, Muralidhar;
Rowinsky, Eric K.;
Takimoto, Chris H.;
Ng, Chee M.;
Geyer Jr., Charles E.;
Denis, Louis J.;
De Bono, Johann S.;
Hao, Desiree;
Tolcher, Anthony W.;
Rha, Sun-Young;
Jolivet, Jacques;
Patnaik, Amita

Publication type:

Article

Phase I study of paclitaxel poliglumex administered weekly for patients with advanced solid malignancies.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 287, doi. 10.1007/s00280-008-0869-5

By:

Mita, Monica;
Mita, Alain;
Sarantopoulos, John;
Takimoto, Chris H.;
Rowinsky, Eric K.;
Romero, Ofelia;
Angiuli, Patrizia;
Allievi, Cecilia;
Eisenfeld, Amy;
Verschraegen, Claire F.

Publication type:

Article

Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trial.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 295, doi. 10.1007/s00280-006-0389-0

By:

Dragovich, Tomislav;
Huberman, Mark;
Von Hoff, Daniel D.;
Rowinsky, Eric K.;
Nadler, Paul;
Wood, Debra;
Hamilton, Marta;
Hage, George;
Wolf, Julie;
Patnaik, Amita

Publication type:

Article

A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 2, p. 165, doi. 10.1007/s00280-006-0255-0

By:

Mita, Monica M.;
Rowinsky, Eric K.;
Forero, Leonardo;
Eckhart, S. Gail;
Izbicka, Elzbieta;
Weiss, Geoffrey R.;
Beeram, Muralidhar;
Mita, Alain C.;
de Bono, Johann S.;
Tolcher, Anthony W.;
Hammond, Lisa A.;
Simmons, Paul;
Berg, Kristin;
Takimoto, Chris;
Patnaik, Amita

Publication type:

Article

Bioavailability of penclomedine and systemic exposure to 4-O-demethylpenclomedine in patients receiving oral and intravenous penclomedine.

Published in:

2001

By:

O'Reilly, Seamus;
Hartman, Neil R.;
Bowling, Katherine M.;
Rowinsky, Eric K.;
Donehower, Ross C.;
Collins, Jerry;
Strong, John M.;
O'Reilly, S;
Hartman, N R;
Bowling, K M;
Rowinsky, E K;
Donehower, R C;
Collins, J;
Strong, J M

Publication type:

journal article

Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studies.

Published in:

Annals of Neurology, 1994, v. 35, n. 3, p. 304, doi. 10.1002/ana.410350310

By:

Chaudhry, Vinay;
Rowinsky, Eric K.;
Sartorius, Susan E.;
Donehower, Ross C.;
Cornblath, David R.

Publication type:

Article

Inhibiting Signal Transduction: Recent Advances in the Development of Receptor Tyrosine Kinase and Ras Inhibitors.

Published in:

Cancer Investigation, 2002, v. 20, n. 3, p. 387, doi. 10.1081/CNV-120001184

By:

Hao, Desirée;
Rowinsky, Eric K.

Publication type:

Article

The rapamycin-sensitive signal transduction pathway as a target for cancer therapy.

Published in:

Oncogene, 2000, v. 19, n. 56, p. 6680, doi. 10.1038/sj.onc.1204091

By:

Hidalgo, Manuel;
Rowinsky, Eric K

Publication type:

Article

Activity of multitargeted antifolate (pemetrexed disodium, LY231514) in patients with advanced colorectal carcinoma.

Published in:

Cancer (0008543X), 2000, v. 88, n. 8, p. 1807, doi. 10.1002/(SICI)1097-0142(20000415)88:8<1807::AID-CNCR8>3.0.CO;2-L

By:

John, William;
Picus, Joel;
Blanke, Charles D.;
Clark, Jeffery W.;
Schulman, Lawrence N.;
Rowinsky, Eric K.;
Thornton, Donald E.;
Loehrer, Patrick J.

Publication type:

Article

Therapeutics targeting signal transduction for patients with colorectal carcinoma.

Published in:

British Medical Bulletin, 2002, v. 64, n. 1, p. 227, doi. 10.1093/bmb/64.1.227

By:

De Bono, Johann S.;
Rowinsky, Eric K.

Publication type:

Article

Population pharmacokinetic and adverse event analysis of topotecan in patients with solid tumors.

Published in:

Clinical Pharmacology & Therapeutics, 2002, v. 71, n. 5, p. 334, doi. 10.1067/mcp.2002.123553

By:

Mould, Diane R.;
Holford, Nicholas H. G.;
Schellens, Jan H. M.;
Beijnen, Jos H.;
Hutson, Paul R.;
Rosing, Hilde;
ten Bokkel Huinink, Willem W.;
Rowinsky, Eric K.;
Schiller, Joan H.;
Russo, Mark;
Ross, Graham

Publication type:

Article

Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001.

Published in:

2002

By:

Baker, Sharyn D.;
Jaap Verweij;
Rowinsky, Eric K.;
Donehower, Ross C.;
Schellens, Jan H.M.;
Grochow, Louise B.;
Sparreboom, Alex;
Verweij, Jaap

Publication type:

journal article

The Current Status of Camptothecin Analogues as Antitumor Agents.

Published in:

JNCI: Journal of the National Cancer Institute, 1993, v. 85, n. 4, p. 271, doi. 10.1093/jnci/85.4.271

By:

Slichenmyer, William J.;
Rowinsky, Eric K.;
Donehower, Ross C.;
Kaufmann, Scott H.

Publication type:

Article

Factors Affecting Topotecan Sensitivity in Human Leukemia Samples<sup>a</sup>.

Published in:

Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 128, doi. 10.1111/j.1749-6632.1996.tb26382.x

By:

KAUFMANN, SCOTT H.;
GORE, STEVEN D.;
LETENDRE, LOUIS;
SVINGEN, PHYLLIS A.;
KOTTKE, TIMOTHY;
BUCKWALTER, CHRISTOPHER A.;
JONES, RICHARD J.;
GROCHOW, LOUISE B.;
BURKE, PHILIP J.;
DONEHOWER, ROSS C.;
ROWINSKY, ERIC K.

Publication type:

Article

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms.

Published in:

1989

By:

McGuire, William P.;
Rowinsky, Eric K.;
Rosenshein, Neil B.;
Grumbine, Francis C.;
Ettinger, David S.;
Armstrong, Deborah K.;
Donehower, Ross C.;
McGuire, W P;
Rowinsky, E K;
Rosenshein, N B;
Grumbine, F C;
Ettinger, D S;
Armstrong, D K;
Donehower, R C

Publication type:

journal article

SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia.

Published in:

British Journal of Haematology, 2014, v. 166, n. 6, p. 862, doi. 10.1111/bjh.12978

By:

Frolova, Olga;
Benito, Juliana;
Brooks, Chris;
Wang, Rui‐Yu;
Korchin, Borys;
Rowinsky, Eric K.;
Cortes, Jorge;
Kantarjian, Hagop;
Andreeff, Michael;
Frankel, Arthur E.;
Konopleva, Marina

Publication type:

Article

SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia.

Published in:

British Journal of Haematology, 2014, v. 165, n. 5, p. 862, doi. 10.1111/bjh.12978

By:

Frolova, Olga;
Benito, Juliana;
Brooks, Chris;
Rui-Yu Wang;
Korchin, Borys;
Rowinsky, Eric K.;
Cortes, Jorge;
Kantarjian, Hagop;
Andreeff, Michael;
Frankel, Arthur E.;
Konopleva, Marina

Publication type:

Article

Pilot Trial of Alternating Paclitaxel and Doxorubicin in Advanced Breast Cancer.

Published in:

Breast Journal, 1997, v. 3, n. 1, p. 19, doi. 10.1111/j.1524-4741.1997.tb00136.x

By:

McCaskill-Stevens, Worta J.;
Sparano, Joseph A.;
Cobleigh, Melody;
Robert, Nicholas J.;
Baughman, Carla;
Neuberg, Donna;
Rowinsky, Eric K.;
Sledge, George W.

Publication type:

Article

Vascular Endothelial Growth Factor Receptor-1 in Human Cancer.

Published in:

Cancer (0008543X), 2010, v. 116, p. 1027

By:

Schwartz, Jonathan D.;
Rowinsky, Eric K.;
Youssoufian, Hagop;
Pytowski, Bronislaw;
Wu, Yan

Publication type:

Article

Rationale for the Development of IMC-3G3, a Fully Human Immunoglobulin C Subclass 1 Monoclonal Antibody Targeting the Platelet- Derived Growth Factor Receptor α.

Published in:

Cancer (0008543X), 2010, v. 116, p. 1018

By:

Shah, Gaurav D.;
Loizos, Nick;
Youssoufian, Hagop;
Schwartz, Jonathan D.;
Rowinsky, Eric K.

Publication type:

Article

Targeting FMS-Related Tyrosine Kinase Receptor 3 With the Human Immunoglobulin G1 Monoclonal Antibody IMC-EB10.

Published in:

Cancer (0008543X), 2010, v. 116, p. 1013

By:

Youssoufian, Hagop;
Rowinsky, Eric K.;
Tonra, James;
Li, Yiwen

Publication type:

Article

Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma.

Published in:

Investigational New Drugs, 2020, v. 38, n. 5, p. 1448, doi. 10.1007/s10637-020-00915-4

By:

Rowinsky, Eric K.;
Paner, Agne;
Berdeja, Jesus G.;
Paba-Prada, Claudia;
Venugopal, Parameswaran;
Porkka, Kimmo;
Gullbo, Joachim;
Linder, Stig;
Loskog, Angelica;
Richardson, Paul G.;
Landgren, Ola

Publication type:

Article

Taxol: Twenty Years Later, the Story Unfolds.

Published in:

JNCI: Journal of the National Cancer Institute, 1991, v. 83, n. 24, p. 1778

By:

Rowinsky, Eric K.;
Donehower, Ross C.

Publication type:

Article

Effects of the Differentiating Agent Hexamethylene Bisacetamide on Normal and Myelodysplastic Hematopoietic Progenitors.

Published in:

JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 24, p. 1926

By:

Rowinsky, Eric K.;
Donehower, Ross C.;
Spivak, Jerry L.;
Burke, Philip J.;
Griffin, Constance A.;
Jones, Richard J.

Publication type:

Article

Taxol: A Novel Investigational Antimicrotubule Agent.

Published in:

JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 15, p. 1247

By:

Rowinsky, Eric K.;
Cazenave, Lorranie A.;
Donehower, Ross C.

Publication type:

Article

Response.

Published in:

JNCI: Journal of the National Cancer Institute, 1989, v. 81, n. 10, p. 815

By:

DONEHOWER, ROSS C.;
NOE, DENNIS A.;
HANTEL, ALEXANDER;
ROWINSKY, ERIC K.;
VITO, BARBARA L.;
MCGUIRE, WILLIAM P.;
ETTINGER, DAVID S.

Publication type:

Article

Phase I Trial of Trimetrexate Glucuronate on a Five-Day Bolus Schedule: Clinical Pharmacology and Pharmacodynamics.

Published in:

JNCI: Journal of the National Cancer Institute, 1989, v. 81, n. 2, p. 124

By:

Grochow, Louise B.;
Noe, Dennis A.;
Dole, Gregory B.;
Rowinsky, Eric K.;
Ettinger, David S.;
Graham, Michael L.;
McGuire, William P.;
Donehower, Ross C.

Publication type:

Article

Clinical and Pharmacologic Reappraisal of Dichloromethotrexate.

Published in:

JNCI: Journal of the National Cancer Institute, 1988, v. 80, n. 19, p. 1547

By:

Hantel, Alexander;
Rowinsky, Eric K.;
Noe, Dennis A.;
McGuire, William P.;
Grochow, Louise B.;
Vito, Barbara L.;
Ettinger, David S.;
Donehower, Ross C.

Publication type:

Article

Clinical Pharmacology of Oral and Iv N-Methylformamide: A Pharmacologic Basis for Lack of Clinical Antineoplastic Activity2.

Published in:

JNCI: Journal of the National Cancer Institute, 1988, v. 80, n. 9, p. 671

By:

Rowinsky, Eric K.;
Noe, Dennis A.;
Orr, Douglas W.;
Grochow, Louise B.;
Ettinger, David S.;
Donehower, Ross C.

Publication type:

Article

Targeting the target of rapamycin (TOR): looking to mother nature.

Published in:

2011

By:

Rowinsky, Eric;
Rowinsky, Eric K

Publication type:

Editorial